Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome

Cerebrovascular Diseases

Volumn 33, Issue 5, 2012, Pages 446-452

  Paliwal, Prakash R ^a   Ahmad, Aftab ^a   Shen, Liang ^a   Yeo, Leonard L L ^a   Loh, Pei Kee ^a   Ng, Kay W P ^a   Chong, Vincent F ^a   Ong, Benjamin K C ^a   Venketasubramanian, N ^a   Sinha, Arvind K ^a   Teoh, Hock L ^a   Bathla, Girish ^a   Chan, Bernard P L ^a   Sharma, Vijay K ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Acute ischemic stroke; Brain computerized tomography; Hyperdense middle cerebral artery sign; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN CIRCULATION; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HYPERDENSE MIDDLE CEREBRAL ARTERY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; NEUROLOGIC DISEASE; PREDICTION; PRIORITY JOURNAL; RANKIN SCALE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE; YOUNG ADULT;

EID: 84858958231     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000336863     Document Type: Article

References (25)

1. Bastianello S, Pierallini A, Colonnese C, Brughitta G, Angeloni U, Antonelli M, et al: Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology 1991; 33: 207-211.
2. Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X: Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 1992; 23: 317-324.
3. Wardlaw JM, Mielke O: Early signs of brain infarction at CT: Observer reliability and outcome after thrombolytic treatment-systematic review. Radiology 2005; 235: 444-453. (Pubitemid 40571081)
4. Tomsick T, Brott T, Barsan W, Broderick J, Haley EC, Spilker J, Khoury J: Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996; 17: 79-85. (Pubitemid 26024712)
5. Manelfe C, Larrue V, von Kummer R, Bozzao L, Ringleb P, Bastianello S, Iweins F, Lesaffre E: Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 1999; 30: 769-772. (Pubitemid 29156366)
6. Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Janjua N, Diwani AA: Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology 2006; 66: 1171-1174.
7. Tsao JW, Gean AD, Glenn OA, Bonovich DC: Hyperdense MCA resolved after tPA. Neurology 2002; 58: 1512. (Pubitemid 34552958)
8. Garg N, Eshkar N, Tanenbaum L, Cohen B, Sen S: Computed tomography angiographic correlates of early computed tomography signs in acute ischemic stroke. J Neuroimaging 2004; 14: 242-245. (Pubitemid 38781395)
9. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993; 14: 3-13. (Pubitemid 23055914)
10. von Kummer R, Meyding-Lamadé U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K: Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 1994; 15: 9-15.
11. Muir KW, Buchan A, von Kummer R, Rother J, Baron JC: Imaging of acute stroke. Lancet Neurol 2006; 5: 755-768. (Pubitemid 44205513)
12. Kharitonova T, Thorén M, Ahmed N, Wardlaw JM, von Kummer R, Thomassen L, Wahlgren N, SITS investigators: Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: Clinical course and prognostic significance. J Neurol Neurosurg Psychiatry 2009; 80: 273-278.
13. Agarwal P, Kumar S, Hariharan S, Eshkar N, Verro P, Cohen B, Sen S: Hyperdense middle cerebral artery sign: Can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Cerebrovasc Dis 2004; 17: 182-190. (Pubitemid 38529196)
14. Kharitonova T, Ahmed N, Thorén M, Wardlaw JM, von Kummer R, Glahn J, Wahlgren N: Hyperdense middle cerebral artery sign on admission CT scan -Prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis 2009; 27: 51-59.
15. The National Institute of Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
16. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G, SITS-MOST investigators: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study. Lancet 2007; 369: 275-282. (Pubitemid 46138121)
17. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS: Stroke: Neurologic and functional recovery. The Copenhagen Stroke Study. Phys Med Rehabil Clin N Am 1999; 10: 887-906.
18. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41. (Pubitemid 23014379)
19. Gacs G, Fox AJ, Barnett HJ, Vinuela F: CT visualization of intracranial arterial thromboembolism. Stroke 1983; 14: 756-762. (Pubitemid 13012351)
20. Tomsick TA, Brott TG, Olinger CP, Barsan W, Spilker J, Eberle R, Adams H: Hyperdense middle cerebral artery: Incidence and quantitative significance. Neuroradiology 1989; 31: 312-315. (Pubitemid 19239749)
21. Schuierer G, Huk W: The unilateral hyperdense middle cerebral artery: An early CTsign of embolism or thrombosis. Neuroradiology 1988; 30: 120-122.
22. Tomsick T, Brott T, Barsan W, Broderick J, Haley EC, Spilker J: Thrombus localization with emergency cerebral CT. AJNR Am J Neuroradiol 1992; 13: 257-263.
23. Derex L, Hermier M, Adeleine P, Pialat JB, Wiart M, Berthezène Y, Philippeau F, Honnorat J, Froment JC, Trouillas P, Nighoghossian N: Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator . J Neurol Neurosurg Psychiatry 2005; 76: 70-75. (Pubitemid 40013493)
24. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA: Intravenous tissuetype plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000; 283: 1145-1150. (Pubitemid 30126602)
25. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, Calleja S, Garami Z, Khan K, Akhtar N, O'Rourke F, Shuaib A, Demchuk AM, Alexandrov AV, CLOTBUST Investigators: Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: A multicenter transcranial Doppler study. Stroke 2007; 38: 69-74. (Pubitemid 46035608)